Pretreatment Serum Hemoglobin Level and a Preliminary Investigation of Intratumoral Microvessel Density in Advanced Ovarian Cancer

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2004.07.053
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Microvessel Density (MVD) in Locally Advanced Breast Cancer

Asian Pacific Journal of Cancer Prevention
2019English

The Investigation of Tumoral Angiogenesis With HIF-1 Alpha and Microvessel Density in Women With Endometrium Cancer

Journal of the Turkish German Gynecology Association
GynecologyObstetrics
2012English

Augmented Mast Cell Infiltration and Microvessel Density in Prostate Cancer

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2013English

Predictors of Pretreatment CA125 at Ovarian Cancer Diagnosis: A Pooled Analysis in the Ovarian Cancer Association Consortium

Cancer Causes and Control
Cancer ResearchOncology
2017English

Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients With Lung Adenocarcinoma

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Treatment Decisions in Advanced Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Prognostic Role of Preoperative Serum Albumin in Patients With Advanced Ovarian Cancer Undergoing Primary Debulking Surgery

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

PROFAST: ERAS in Advanced Ovarian Cancer, a Randomised Trial

Clinical Nutrition ESPEN
EndocrinologyNutritionMetabolismDieteticsDiabetes
2016English

Amifostine Pretreatment for Protection Against Cyclophosphamide-Induced and Cisplatin-Induced Toxicities: Results of a Randomized Control Trial in Patients With Advanced Ovarian Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy